Kaiser Permanente is an integrated delivery system: medications must be prescribed by Kaiser physicians and dispensed through Kaiser pharmacies. Coverage policies are set by Kaiser's pharmacy and therapeutics committee.
Type 2 diabetes coverage
Generally covered for T2D. Kaiser physicians prescribe through Kaiser pharmacy.
Weight management coverage
Kaiser covers Wegovy and Zepbound for weight indication under specific eligibility criteria, prescribed by Kaiser obesity-medicine clinicians. The integrated model means access is gated through Kaiser primary care or obesity specialist referral.
Cardiovascular indication coverage
Coverage under March 2024 Wegovy CV indication available for Kaiser members meeting SELECT criteria.
OSA indication coverage
Coverage of Zepbound for OSA expanding within Kaiser.
Prior authorization criteria (typical)
Kaiser eligibility criteria are typically similar to other commercial PAs but evaluated by Kaiser clinicians.
If your plan excludes weight-management drugs
Cash-pay compounded GLP-1 from external telehealth providers is an alternative path if Kaiser-internal coverage is not workable.
How to verify
The most reliable way to verify coverage is to call the member services number on your insurance card and ask: (1) Is [Wegovy/Zepbound/Ozempic/Mounjaro] on my formulary? (2) What tier? (3) What are the prior authorization criteria? (4) What's my expected copay at each tier? Document the date, the rep's name, and any reference number.
Cash-pay alternative
If insurance coverage is unworkable, see our price index for current cash-pay compounded options. NexLife, our editorial pick, lists compounded semaglutide at $95–$109 and tirzepatide at $115–$129 a month depending on plan length (prices as of November 6, 2026); see the NexLife review.